Hikma Pharmaceuticals (OTCMKTS:HKMPF) Trading Down 4.5% – What’s Next?

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) traded down 4.5% during mid-day trading on Wednesday . The company traded as low as $22.56 and last traded at $22.56. 436 shares were traded during mid-day trading, a decline of 38% from the average session volume of 698 shares. The stock had previously closed at $23.62.

Wall Street Analysts Forecast Growth

Separately, Citigroup upgraded Hikma Pharmaceuticals to a “strong-buy” rating in a research note on Friday, August 9th.

Hikma Pharmaceuticals Price Performance

The stock has a 50-day moving average of $25.20 and a 200-day moving average of $24.98. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.98 and a current ratio of 1.66.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.